Kuhnil about to acquire approval of world’s first children sleep medication

Published: 2016-11-25 15:19:19

Updated: 2016-11-25 15:19:19

On the 23^rd of November, Kuhnil Pharm(CEO Young-Joong Kim, Jae-Hee Choi) announced it was informed the Phase 3 clinical trial of Circadilly that will be introduced from Israeli Neurim was successfully completed.

Circadilly that is recently completed in the Phase 3 clinical trial is a product that was finished with clinical trials in 9 years after acquiring approval for the sleep medication(Cir...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.